Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 186

1.

Daylight photodynamic therapy with methyl aminolevulinate cream is as effective as conventional photodynamic therapy with blue light in the treatment of actinic keratosis: a controlled randomised intra-individual study.

Assikar S, Labrunie A, Kerob D, Couraud A, Bédane C.

J Eur Acad Dermatol Venereol. 2020 Jan 19. doi: 10.1111/jdv.16208. [Epub ahead of print]

PMID:
31955461
2.

Reactivation of pemphigus by varicella zoster virus after anti-CD20 treatment.

Douard PA, Delaumenie S, Pittoni J, Assikar S, Matei I, Prudhomme R, Audevard D, Bédane C.

Int J Dermatol. 2019 Dec 15. doi: 10.1111/ijd.14711. [Epub ahead of print] No abstract available.

PMID:
31840226
3.

Author Correction: B-cell depletion induces a shift in self antigen specific B-cell repertoire and cytokine pattern in patients with bullous pemphigoid.

Berkani N, Joly P, Golinski ML, Colliou N, Lim A, Larbi A, Riou G, Caillot F, Bernard P, Bedane C, Delaporte E, Chaby G, Dompmartin A, Hertl M, Calbo S, Musette P.

Sci Rep. 2019 Dec 9;9(1):18991. doi: 10.1038/s41598-019-54421-6.

4.

Man of stone: A case of a chronic actinic dermatitis mimicking a cutis verticis gyrata.

Bourgaux M, Marcaillou M, Matei I, Delaumenie S, Prud'homme R, Souyri N, Bedane C.

J Eur Acad Dermatol Venereol. 2019 Nov 12. doi: 10.1111/jdv.16068. [Epub ahead of print] No abstract available.

PMID:
31715028
5.

Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid-sparing effect.

Chen DM, Odueyungbo A, Csinady E, Gearhart L, Lehane P, Cheu M, Maho-Vaillant M, Prost-Squarcioni C, Hebert V, Houivet E, Calbo S, Caillot F, Golinski ML, Labeille B, Picard-Dahan C, Paul C, Richard MA, Bouaziz JD, Duvert-Lehembre S, Bernard P, Caux F, Alexandre M, Ingen-Housz-Oro S, Vabres P, Delaporte E, Quereux G, Dupuy A, Debarbieux S, Avenel-Audran M, D'Incan M, Bedane C, Bénéton N, Jullien D, Dupin N, Misery L, Machet L, Beylot-Barry M, Dereure O, Sassolas B, Benichou J, Musette P, Joly P; French Study Group on Autoimmune Bullous Diseases.

Br J Dermatol. 2019 Sep 5. doi: 10.1111/bjd.18482. [Epub ahead of print]

PMID:
31487383
6.

[Phototesting in France: A survey by French Society for Photodermatology].

Moreau A, Avenel-Audran M, Adamski H, Aubin F, Beani JC, Bedane C, Bonnevalle A, Boulitrop C, Bourrain JL, Boursault L, Dutartre H, Jeanmougin M, Leonard F, Machet L, Marguery MC, Rouchouse B, Schmutz JL; Groupe de la Société française de photodermatologie.

Ann Dermatol Venereol. 2019 Sep;146(8-9):577-581. doi: 10.1016/j.annder.2019.03.004. Epub 2019 May 15. French. No abstract available.

PMID:
31101384
7.

[Update of the French recommendations for the management of pemphigus].

Jelti L, Prost-Squarcioni C, Ingen-Housz-Oro S, Caux F, Bernard P, Bedane C, Alexandre M, Dereure O, Quereux G, Le Bidre E, Plée J, Picard-Dahan C, Le Roux-Villet C, Duvert-Lehembre S, Richard MA, Delaporte E, Debarbieux S, Jullien D, D'Incan M, Konstantinou MP, Bouaziz JD, Tancrède-Bohin E, Doutre MS, Bourgault Villada I, Cordel N, Sassolas B, Viguier MA, Mellottée B, Jouen F, Hebert V, Joly P; Centre de référence des maladies bulleuses auto-immunes (MALIBUL); Groupe Bulles de la SFD et la Filière des maladies rares dermatologiques (FIMARAD).

Ann Dermatol Venereol. 2019 Apr;146(4):279-286. doi: 10.1016/j.annder.2019.01.018. Epub 2019 Mar 29. French. No abstract available.

PMID:
30929874
8.

B-cell depletion induces a shift in self antigen specific B-cell repertoire and cytokine pattern in patients with bullous pemphigoid.

Berkani N, Joly P, Golinski ML, Colliou N, Lim A, Larbi A, Riou G, Caillot F, Bernard P, Bedane C, Delaporte E, Chaby G, Dompmartin A, Hertl M, Calbo S, Musette P.

Sci Rep. 2019 Mar 5;9(1):3525. doi: 10.1038/s41598-019-40203-7. Erratum in: Sci Rep. 2019 Dec 9;9(1):18991.

9.

Impregnated acetate gauze compared with lipido-colloid contact layer at dressing removal pain: a single-blind cross-over randomised control trial.

Meaume S, Thomas P, Truchetet F, Celerier P, Becherel PA, Teot L, Bedane C.

J Wound Care. 2019 Feb 2;28(2):89-101. doi: 10.12968/jowc.2019.28.2.89.

PMID:
30767647
10.

Methotrexate is safe and efficient as long-term treatment for bullous pemphigoid.

Delaumenie S, Assikar S, Prudhomme R, Matei I, Souyri N, Dalmay F, Bedane C.

Eur J Dermatol. 2019 Apr 1;29(2):217-218. doi: 10.1684/ejd.2019.3501. No abstract available.

PMID:
30734720
11.

Large International Validation of ABSIS and PDAI Pemphigus Severity Scores.

Hébert V, Boulard C, Houivet E, Duvert Lehembre S, Borradori L, Della Torre R, Feliciani C, Fania L, Zambruno G, Camaioni DB, Didona B, Marinovic B, Schmidt E, Schumacher N, Hünefeld C, Schanz S, Kern JS, Hofmann S, Bouyeure AC, Picard-Dahan C, Prost-Squarcioni C, Caux F, Alexandre M, Ingen-Housz-Oro S, Bagot M, Tancrede-Bohin E, Bouaziz JD, Franck N, Vabres P, Labeille B, Richard MA, Delaporte E, Dupuy A, D'Incan M, Quereux G, Skowro F, Paul C, Livideanu CB, Beylot-Barry M, Doutre MS, Avenel-Audran M, Bedane C, Bernard P, Machet L, Maillard H, Jullien D, Debarbieux S, Sassolas B, Misery L, Abasq C, Dereure O, Lagoutte P, Ferranti V, Werth VP, Murrell DF, Hertl M, Benichou J, Joly P; French Study Group on Autoimmune Bullous Skin Diseases; Autoimmune Bullous Skin Disease Task Force of the European Academy of Dermatology and Venereology.

J Invest Dermatol. 2019 Jan;139(1):31-37. doi: 10.1016/j.jid.2018.04.042. Epub 2018 Oct 6. Review.

12.

Incidence and Mortality of Pemphigus in France.

Jelti L, Cordel N, Gillibert A, Lacour JP, Uthurriague C, Doutre MS, Delaporte E, Duvert-Lehembre S, Quereux G, Dupuy A, Adamski H, Bedane C, Misery L, Abasq Thomas C, Fleuret C, Bernard P, Chaby G, D'incan M, Verneuil L, Litrowski N, Joly P; French Study Group on Autoimmune Blistering Diseases.

J Invest Dermatol. 2019 Feb;139(2):469-473. doi: 10.1016/j.jid.2018.07.042. Epub 2018 Sep 17. No abstract available.

PMID:
30236611
13.

Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) associated with pristinamycin, secnidazole, and nefopam, with a review of the literature.

Nespoulous L, Matei I, Charissoux A, Bédane C, Assikar S.

Contact Dermatitis. 2018 Dec;79(6):378-380. doi: 10.1111/cod.13084. Epub 2018 Jul 30. Review. No abstract available.

PMID:
30062790
14.

Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes in Advanced Melanoma Patients.

Saint-Jean M, Knol AC, Volteau C, Quéreux G, Peuvrel L, Brocard A, Pandolfino MC, Saiagh S, Nguyen JM, Bedane C, Basset-Seguin N, Khammari A, Dréno B.

J Immunol Res. 2018 Mar 19;2018:3530148. doi: 10.1155/2018/3530148. eCollection 2018.

15.

The Regibul Register: A Tool for Monitoring the Distribution and Incidence of Autoimmune Bullous Dermatoses in Three French Regions, 2010 to 2015.

Loget J, Barbe C, Duvert-Lehembre S, Bédane C, Maizières M, Joly P, Couraud A, Plée J, Bernard P.

Acta Derm Venereol. 2018 Mar 13;98(3):380-381. doi: 10.2340/00015555-2848. No abstract available.

16.

Real-world treatment patterns and clinical outcomes in advanced cutaneous melanoma patients in France.

Sassolas B, Leccia MT, Godard C, Benmahamed L, Flinois A, Levy-Bachelot L, Bédane C.

J Eur Acad Dermatol Venereol. 2018 Apr;32(4):587-594. doi: 10.1111/jdv.14606. Epub 2017 Oct 17.

PMID:
28960564
17.

STAT3 Mediates Nilotinib Response in KIT-Altered Melanoma: A Phase II Multicenter Trial of the French Skin Cancer Network.

Delyon J, Chevret S, Jouary T, Dalac S, Dalle S, Guillot B, Arnault JP, Avril MF, Bedane C, Bens G, Pham-Ledard A, Mansard S, Grange F, Machet L, Meyer N, Legoupil D, Saiag P, Idir Z, Renault V, Deleuze JF, Hindie E, Battistella M, Dumaz N, Mourah S, Lebbe C; GCC (French Group of Skin Cancer).

J Invest Dermatol. 2018 Jan;138(1):58-67. doi: 10.1016/j.jid.2017.07.839. Epub 2017 Aug 24.

18.

First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial.

Joly P, Maho-Vaillant M, Prost-Squarcioni C, Hebert V, Houivet E, Calbo S, Caillot F, Golinski ML, Labeille B, Picard-Dahan C, Paul C, Richard MA, Bouaziz JD, Duvert-Lehembre S, Bernard P, Caux F, Alexandre M, Ingen-Housz-Oro S, Vabres P, Delaporte E, Quereux G, Dupuy A, Debarbieux S, Avenel-Audran M, D'Incan M, Bedane C, Bénéton N, Jullien D, Dupin N, Misery L, Machet L, Beylot-Barry M, Dereure O, Sassolas B, Vermeulin T, Benichou J, Musette P; French study group on autoimmune bullous skin diseases.

Lancet. 2017 May 20;389(10083):2031-2040. doi: 10.1016/S0140-6736(17)30070-3. Epub 2017 Mar 22.

PMID:
28342637
19.

Anti-PD1-induced psoriasis: a study of 21 patients.

Bonigen J, Raynaud-Donzel C, Hureaux J, Kramkimel N, Blom A, Jeudy G, Breton AL, Hubiche T, Bedane C, Legoupil D, Pham-Ledard A, Charles J, Pérol M, Gérard E, Combemale P, Bonnet D, Sigal ML, Mahé E; Groupe de Recherche sur le Psoriasis and the Groupe Cancérologie Cutanée of the Société Française de Dermatologie the GEM Resopso, Apsoderm and the Groupe Français de Pneumo-Cancérologie.

J Eur Acad Dermatol Venereol. 2017 May;31(5):e254-e257. doi: 10.1111/jdv.14011. Epub 2016 Nov 7. No abstract available.

PMID:
27739129
20.

Visible light-induced solar urticaria is improved by omalizumab.

Moncourier M, Assikar S, Matei I, Souyri N, Couture M, Rigot E, Delauménie S, Bédane C.

Photodermatol Photoimmunol Photomed. 2016 Sep;32(5-6):314-316. doi: 10.1111/phpp.12271. Epub 2016 Sep 29. No abstract available.

PMID:
27622987
21.

Integrating longitudinal serum IL-17 and IL-23 follow-up, along with autoantibodies variation, contributes to predict bullous pemphigoid outcome.

Plée J, Le Jan S, Giustiniani J, Barbe C, Joly P, Bedane C, Vabres P, Truchetet F, Aubin F, Antonicelli F, Bernard P.

Sci Rep. 2015 Dec 14;5:18001. doi: 10.1038/srep18001.

22.

Musculoskeletal symptoms in patients with cryopyrin-associated periodic syndromes: a large database study.

Houx L, Hachulla E, Kone-Paut I, Quartier P, Touitou I, Guennoc X, Grateau G, Hamidou M, Neven B, Berthelot JM, Lequerré T, Pillet P, Lemelle I, Fischbach M, Duquesne A, Le Blay P, Le Jeunne C, Stirnemann J, Bonnet C, Gaillard D, Alix L, Touraine R, Garcier F, Bedane C, Jurquet AL, Duffau P, Smail A, Frances C, Grall-Lerosey M, Cathebras P, Tran TA, Morell-Dubois S, Pagnier A, Richez C, Cuisset L, Devauchelle-Pensec V.

Arthritis Rheumatol. 2015 Nov;67(11):3027-36. doi: 10.1002/art.39292.

23.

No major effect of cyclosporin A in patients with severe solar urticaria: a french retrospective case series.

Hurabielle C, Bedane C, Avenel-Audran M, Adamski H, Aubin F, Jeanmougin M, Marguery MC, Peyron JL, Poreaux C, Schmutz JL, Viguier M.

Acta Derm Venereol. 2015 Nov;95(8):1030-1. doi: 10.2340/00015555-2140. No abstract available.

24.

Unusual cutaneous manifestations of late Lyme borreliosis.

Rigot E, Hantz VD, Labrousse F, Martin C, Dubos M, Assikar S, Sparsa A, Bonnetblanc JM, Bedane C.

Eur J Dermatol. 2015 May-Jun;25(3):277-9. doi: 10.1684/ejd.2015.2536. No abstract available.

PMID:
25906406
25.

Sentinel node status and immunosuppression: recurrence factors in localized Merkel cell carcinoma.

Jouary T, Kubica E, Dalle S, Pages C, Duval-Modeste AB, Guillot B, Mansard S, Saiag P, Aubin F, Bedane C, Dalac S, Dompmartin A, Granel-Brocard F, Lok C, Stoebner PE, Lacour JP, Leccia MT, Diallo A, Ezzedine K, Mateus C.

Acta Derm Venereol. 2015 Sep;95(7):835-40. doi: 10.2340/00015555-2099.

26.

[Medicines shortage: Moving towards "regressive" medicine?].

Dupin N, Bédane C.

Ann Dermatol Venereol. 2015 Jun-Jul;142(6-7):391-2. doi: 10.1016/j.annder.2015.01.022. Epub 2015 Feb 17. French. No abstract available.

PMID:
25701097
27.

[Locoregional treatments of brain metastases for patients with metastatic cutaneous melanoma: French national guidelines].

Lubrano V, Derrey S, Truc G, Mirabel X, Thariat J, Cupissol D, Sassolas B, Combemale P, Modiano P, Bedane C, Dygai-Cochet I, Lamant L, Mourrégot A, Rougé Bugat MÈ, Siegrist S, Tiffet O, Mazeau-Woynar V, Verdoni L, Planchamp F, Leccia MT; Institut nationalducancer.

Neurochirurgie. 2014 Dec;60(6):269-75. doi: 10.1016/j.neuchi.2014.05.002. Epub 2014 Sep 17. French.

PMID:
25241016
28.

Severe and refractory solar urticaria treated with intravenous immunoglobulins: a phase II multicenter study.

Aubin F, Porcher R, Jeanmougin M, Léonard F, Bedane C, Moreau A, Schmutz JL, Marguery MC, Adamski H, Viguier M; Société Française de Photodermatologie.

J Am Acad Dermatol. 2014 Nov;71(5):948-953.e1. doi: 10.1016/j.jaad.2014.07.023. Epub 2014 Aug 16.

PMID:
25135650
29.

[Management of patients with metastatic cutaneous melanoma: French national guidelines. French National Cancer Institute].

Leccia MT, Planchamp F, Sassolas B, Combemale P, Modiano P, Bedane C, Cupissol D, Derrey S, Dygai-Cochet I, Lamant L, Lubrano V, Mirabel X, Mourrégot A, Rougé Bugat ME, Siegrist S, Thariat J, Tiffet O, Truc G, Verdoni L, Mazeau-Woynar V.

Ann Dermatol Venereol. 2014 Feb;141(2):111-21. doi: 10.1016/j.annder.2013.10.055. Epub 2013 Dec 26. French. Erratum in: Ann Dermatol Venereol. 2014 May;141(5):404-5.

PMID:
24507205
30.

[Bullous pemphigoid: Particular clinical and immuno-histological profil in a young woman].

Belyamani S, Hali F, Mernissi F, Zamiati S, Bedane C, Benchikhi H.

Presse Med. 2014 Apr;43(4 Pt 1):471-3. doi: 10.1016/j.lpm.2013.07.026. Epub 2014 Jan 17. French. No abstract available.

PMID:
24440766
31.

[Loco-regional treatments of the metastatic sites for patients with pauci-metastatic cutaneous melanoma (without brain metastasis): French national guidelines].

Sassolas B, Mourrégot A, Thariat J, Tiffet O, Dygai-Cochet I, Mirabel X, Truc G, Cupissol D, Modiano P, Combemale P, Bedane C, Derrey S, Lamant L, Lubrano V, Siegrist S, Rougé-Bugat MÈ, Mazeau-Woynar V, Verdoni L, Planchamp F, Leccia MT.

Bull Cancer. 2014 Jan 1;101(1):9-16. doi: 10.1684/bdc.2013.1868. French.

PMID:
24369290
32.

Clinical and immunologic factors associated with bullous pemphigoid relapse during the first year of treatment: a multicenter, prospective study.

Fichel F, Barbe C, Joly P, Bedane C, Vabres P, Truchetet F, Aubin F, Michel C, Jegou J, Grange F, Antonicelli F, Bernard P.

JAMA Dermatol. 2014 Jan;150(1):25-33. doi: 10.1001/jamadermatol.2013.5757.

PMID:
24226428
33.

[Photodynamic therapy in dermatology, other indications and perspectives].

Bédane Ch.

Ann Dermatol Venereol. 2013 Nov;140 Suppl 2:229-35. doi: 10.1016/S0151-9638(13)70139-X. Review. French.

PMID:
24199715
34.

Assessment of the rate of long-term complete remission off therapy in patients with pemphigus treated with different regimens including medium- and high-dose corticosteroids.

Almugairen N, Hospital V, Bedane C, Duvert-Lehembre S, Picard D, Tronquoy AF, Houivet E, D'incan M, Joly P.

J Am Acad Dermatol. 2013 Oct;69(4):583-8. doi: 10.1016/j.jaad.2013.05.016. Epub 2013 Jul 12.

PMID:
23850258
35.

Ipilimumab in melanoma patients with brain metastasis: a retro-spective multicentre evaluation of thirty-eight patients.

Konstantinou MP, Dutriaux C, Gaudy-Marqueste C, Mortier L, Bedane C, Girard C, Thellier S, Jouary T, Grob JJ, Richard MA, Templier C, Sakji L, Guillot B, Paul C, Meyer N.

Acta Derm Venereol. 2014 Jan;94(1):45-9. doi: 10.2340/00015555-1654.

36.

Treatment patterns and outcomes in patients with advanced melanoma in France.

Bedane C, Leccia MT, Sassolas B, Bregman B, Lebbé C; French investigators of the MELODY study.

Curr Med Res Opin. 2013 Oct;29(10):1297-305. doi: 10.1185/03007995.2013.820693. Epub 2013 Jul 26.

PMID:
23808961
37.

Lymphomatoid papulosis type D: an aggressive histology for an indolent disease.

Bertolotti A, Pham-Ledard AL, Vergier B, Parrens M, Bedane C, Beylot-Barry M.

Br J Dermatol. 2013 Nov;169(5):1157-9. doi: 10.1111/bjd.12463. Review. No abstract available.

PMID:
23746266
38.

Long-term remissions of severe pemphigus after rituximab therapy are associated with prolonged failure of desmoglein B cell response.

Colliou N, Picard D, Caillot F, Calbo S, Le Corre S, Lim A, Lemercier B, Le Mauff B, Maho-Vaillant M, Jacquot S, Bedane C, Bernard P, Caux F, Prost C, Delaporte E, Doutre MS, Dreno B, Franck N, Ingen-Housz-Oro S, Chosidow O, Pauwels C, Picard C, Roujeau JC, Sigal M, Tancrede-Bohin E, Templier I, Eming R, Hertl M, D'Incan M, Joly P, Musette P.

Sci Transl Med. 2013 Mar 6;5(175):175ra30. doi: 10.1126/scitranslmed.3005166.

39.

Prevalence and clinical significance of anti-laminin 332 autoantibodies detected by a novel enzyme-linked immunosorbent assay in mucous membrane pemphigoid.

Bernard P, Antonicelli F, Bedane C, Joly P, Le Roux-Villet C, Duvert-Lehembre S, Rousselle P, Prost-Squarcioni C.

JAMA Dermatol. 2013 May;149(5):533-40. doi: 10.1001/jamadermatol.2013.1434.

PMID:
23426192
40.

The France-PDT study: a national prospective observational cohort survey on the use of methyl-aminolevulinate photodynamic therapy in France, with up to 6-month follow-up.

Farhi D, Bedane C, Savary J, Basset-Seguin N.

Eur J Dermatol. 2013 Jan-Feb;23(1):68-76. doi: 10.1684/ejd.2012.1896.

PMID:
23400280
41.

Treatment patterns and outcomes among patients diagnosed with unresectable stage III or IV melanoma in Europe: a retrospective, longitudinal survey (MELODY study).

Lebbe C, Lorigan P, Ascierto P, Testori A, Bédane C, Middleton M, van Baardewijk M, Konto C, Dueymes A, Maio M.

Eur J Cancer. 2012 Nov;48(17):3205-14. doi: 10.1016/j.ejca.2012.05.010. Epub 2012 Jun 27.

PMID:
22742880
42.

[Hypertensive leg ulcers: epidemiological characteristics and prognostic factors for healing in a prospective cohort].

Senet P, Beneton N, Debure C, Modiano P, Lok C, Bedane C, Truchetet F, Fays-Bouchon S, Vicaut E, Chosidow O; Angio-dermatologie de la SFD.

Ann Dermatol Venereol. 2012 May;139(5):346-9. doi: 10.1016/j.annder.2011.09.191. Epub 2012 Feb 1. French.

PMID:
22578337
43.

Economic impact of healthcare resource utilisation patterns among patients diagnosed with advanced melanoma in the United Kingdom, Italy, and France: results from a retrospective, longitudinal survey (MELODY study).

Johnston K, Levy AR, Lorigan P, Maio M, Lebbe C, Middleton M, Testori A, Bédane C, Konto C, Dueymes A, Sbarigia U, van Baardewijk M.

Eur J Cancer. 2012 Sep;48(14):2175-82. doi: 10.1016/j.ejca.2012.03.003. Epub 2012 Apr 3.

PMID:
22480965
44.

Incidence and mortality of bullous pemphigoid in France.

Joly P, Baricault S, Sparsa A, Bernard P, Bédane C, Duvert-Lehembre S, Courville P, Bravard P, Rémond B, Doffoel-Hantz V, Bénichou J.

J Invest Dermatol. 2012 Aug;132(8):1998-2004. doi: 10.1038/jid.2012.35. Epub 2012 Mar 15.

45.

[Historic malignant tumour: 27 observations].

Sparsa A, Doffoel-Hantz V, Durox H, Gaston J, Delage-Core M, Bédane C, Labrousse F, Sannajust JP, Bonnetblanc JM.

Ann Dermatol Venereol. 2012 Mar;139(3):189-93. doi: 10.1016/j.annder.2011.11.009. Epub 2011 Dec 26. French.

PMID:
22401683
46.

Photodynamic therapy can improve warts' discomfort in renal transplant patients prospective multicenter study.

Sparsa A, Blaise S, Tack B, Dalmay F, Leroy D, Bonnetblanc JM, Béani JC, Bédane C.

Photochem Photobiol. 2012 Jul-Aug;88(4):1023-6. doi: 10.1111/j.1751-1097.2012.01114.x. Epub 2012 Mar 30.

PMID:
22332671
47.

[Photodynamic therapy for the treatment of extramammary Paget's disease].

Clément E, Sparsa A, Doffoel-Hantz V, Durox H, Prey S, Bonnetblanc JM, Caly H, Aubard Y, Bedane C.

Ann Dermatol Venereol. 2012 Feb;139(2):103-8. doi: 10.1016/j.annder.2011.10.414. Epub 2011 Dec 26. French.

PMID:
22325748
48.

Adjuvant prophylactic regional radiotherapy versus observation in stage I Merkel cell carcinoma: a multicentric prospective randomized study.

Jouary T, Leyral C, Dreno B, Doussau A, Sassolas B, Beylot-Barry M, Renaud-Vilmer C, Guillot B, Bernard P, Lok C, Bedane C, Cambazard F, Misery L, Estève E, Dalac S, Machet L, Grange F, Young P, Granel-Brocard F, Truchetet F, Vergier B, Delaunay MM, Grob JJ; Groupe de Cancérologie Cutanée of the Société Française de Dermatologie.

Ann Oncol. 2012 Apr;23(4):1074-80. doi: 10.1093/annonc/mdr318. Epub 2011 Jul 12.

PMID:
21750118
49.

Solar urticaria treated with intravenous immunoglobulins.

Adamski H, Bedane C, Bonnevalle A, Thomas P, Peyron JL, Rouchouse B, Cambazard F, Jeanmougin M, Viguier M.

J Am Acad Dermatol. 2011 Aug;65(2):336-340. doi: 10.1016/j.jaad.2010.05.040. Epub 2011 Apr 22.

PMID:
21514688
50.

[Gardasil®-induced erythema nodosum].

Longueville C, Doffoel-Hantz V, Hantz S, Souyri N, Nouaille Y, Bédane C, Sparsa A.

Rev Med Interne. 2012 Mar;33(3):e17-8. doi: 10.1016/j.revmed.2011.02.013. Epub 2011 Mar 23. French.

PMID:
21435755

Supplemental Content

Loading ...
Support Center